clove and Precancerous-Conditions

clove has been researched along with Precancerous-Conditions* in 2 studies

Other Studies

2 other study(ies) available for clove and Precancerous-Conditions

ArticleYear
Ellagitannins from jabuticaba (Myrciaria jaboticaba) seeds attenuated inflammation, oxidative stress, aberrant crypt foci, and modulated gut microbiota in rats with 1,2 dimethyl hydrazine-induced colon carcinogenesis.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2021, Volume: 154

    Since dietary factors are thought to be responsible for high colon cancer risk, we investigated the chemopreventive effect of jabuticaba seed extract (LJE) by administering yogurt with or without LJE against 1,2 dimethyl hydrazine (DMH)-induced colon carcinogenesis in rats. Results showed that LJE contained a total phenolic content of 57.16 g/100 g of seed extract in which 7.67 and 10.09 g/100 g represented total flavonoids and ellagitannins, respectively. LJE protected DNA and human LDL against induced in vitro oxidation, which was associated with the ellagitannin content and with the free-radical scavenging and reducing capacities. LJE alone had a non-clastogenicity/aneugenicity property, but in combination with cisplatin, it enhanced the chromosome aberrations in cancer cells. In colon cancer-induced rats, yogurt with or without LJE caused a reduction in pro-inflammatory parameters, decreased the RNA expression of antiapoptotic cytokines and increased the expression of proapoptotic cytokines. Moreover, LJE attenuated colon cancer initiation and progression by decreasing aberrant crypt foci and LJE recovered the gut microbiome. Together, this evidence suggests that LJE provides chemopreventive protection against colon cancer development by reducing inflammation and increasing proapoptotic pathways.

    Topics: 1,2-Dimethylhydrazine; Animals; Carcinogens; Chromosome Aberrations; Colonic Neoplasms; Gastrointestinal Microbiome; Hydrolyzable Tannins; Inflammation; Male; Mutagenicity Tests; Myrtaceae; Oxidative Stress; Plant Extracts; Precancerous Conditions; Rats; Rats, Wistar; Seeds

2021
[Cervical cancers diagnosed at the Pasteur Institute of Madagascar from 1992 to 2002].
    Archives de l'Institut Pasteur de Madagascar, 2003, Volume: 69, Issue:1-2

    In Madagascar, the epidemiological data actualized concerning the cancer of the collus of uterus are not available because of the absence of register of cancer. The objective of this study is to achieve a first assessment of the problem, to complete the epidemiological knowledge, to point out the tool of precoce detection of the precancerous lesions, to propose the measures aiming to improve the management of the patients and to contribute to the institution of a register of cancer. This is a retrospective survey on the frequency of the cancer of the cervix observed from 1992 to 2002 about 23,908 withdrawals addressed to the Institut Pasteur de Madagascar for anatomopathological exam and 12,605 cervical smears for cytological exam. In pathological anatomy, 2,621 (63.4%) of 4,136 cases of diagnosed cancer, have been observed in women. 687 cases (26.2%) of them were localized in the collus. The 3/4 of the cancers of the cervix is invasive and the mean age is 48.2 years old at the time of diagnosis. The cytology detects only 74 cases of invasive cancer of which most don't have an histological confirmation. 274 pre-lesions of cervix cancer were diagnosed for this period, the majority lesions are cytological diagnosis. In spite of a non representative recruitment of the general population, and by the number of withdrawals considered, these results may represent indicators of the epidemiological situation and justify the institution of program to detect the precancerous lesions in a national scale.

    Topics: Academic Medical Centers; Academies and Institutes; Adult; Age Distribution; Aged; Aged, 80 and over; Female; Humans; Incidence; Madagascar; Mass Screening; Middle Aged; Needs Assessment; Neoplasm Staging; Papillomavirus Infections; Population Surveillance; Precancerous Conditions; Registries; Retrospective Studies; Risk Factors; Total Quality Management; Uterine Cervical Neoplasms; Vaginal Smears

2003